New technique uses antibodies that are cloned from patients who have recovered from an infection caused by the fungus Candida, stated Medical Research Council Centre for Medical Mycology at the University of Aberdeen researchers and funded by the Wellcome Trust and Medical Research Council.
Despite public health efforts, many people who get fungal infections in their blood streams die, even if they can be identified and treated with antifungal drugs. These therapies are often ineffective on their own and increasingly the infections are becoming resistant to treatment with some of the front line antifungal drugs.
In laboratory experiments, the research team used these cloned antibodies to successfully protect animals from Candidabloodstream infections and demonstrate their potential in both treating and diagnosing Candida infections.
Professor Neil Gow of the University of Exeter, who supervised the research while at Aberdeen, said: "Globally, fungal infections are under-recognised as a major killer. They're hard to detect and for every day we fail to diagnose a serious fungal infection, the chances of survival diminishes. This research brings us a step closer to a day when we can use the antibodies that are generated by the human body to diagnose and treat fungal infections."